News

Stay informed on the forefront of innovation in the field of Cell & Gene Therapies and Nucleic Acids with Anemocyte, the leading Italian company in plasmid DNA and mRNA development and manufacturing.

Our products and services are essential components for the research, development and production of new generation medicines as for example vaccines, immuno-oncology therapies, and protein replacement treatments.

Discover our latest initiatives, technology advancements, expansion plans, and our ongoing commitment to research and development of cutting-edge solutions for Cell & Gene Therapies and Nucleic Acids.

CPHI Milan
CPHI milan event

CPHI Milan

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to CPHI Milan 2024

read more
2400 1800 Anemocyte.com
The Role of Plasmid Sequencing in Gene Therapy
plasmid dna manufacturing news anemocyte

The Role of Plasmid Sequencing in Gene Therapy

Discover the pivotal role of plasmid DNA sequencing in advancing gene therapy. Learn how this groundbreaking technology is driving the development of novel treatments and shaping the future of biomedicine.

read more
1201 900 Anemocyte.com
ATE24 Lisbon
advanced therapies europe

ATE24 Lisbon

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to ATE24 Lisbon, Portugal

read more
2400 1800 Anemocyte.com
Plasmid Manufacturing: From Downstream to Filling
plasmid dna manufacturing news anemocyte

Plasmid Manufacturing: From Downstream to Filling

Downstream process is fine tuned to recover the soluble fraction of plasmidic DNA, whereas the genomic DNA, proteins polysaccharides and total RNA from E. coli cells are precipitated and removed by depth filtration.

read more
1201 900 Anemocyte.com
The Role of Plasmid DNA in Viral Vector Production for Gene Therapy
plasmid dna manufacturing news anemocyte

The Role of Plasmid DNA in Viral Vector Production for Gene Therapy

The utilization of plasmid DNA in the production of viral vectors for gene therapy represents a critical advancement in medical biotechnology.

read more
1201 900 Anemocyte.com
Plasmids for Lentivirus and AAV Manufacturing
plasmid dna manufacturing news anemocyte

Plasmids for Lentivirus and AAV Manufacturing

Lentiviruses and adeno-associated viruses (AAV) require specific plasmids for their production, which ensure efficient vector generation and safe delivery of the gene of interest (GOI).

read more
1201 900 Anemocyte.com
mRNA Manufacturing Process
mrna production

mRNA Manufacturing Process

Many people first became familiar with the term “mRNA” when COVID-19 vaccines were rolled out. In the simplest terms, mRNA, which stands for messenger ribonucleic acid, is a genetic material that instructs the cells to make specific proteins.

read more
1200 900 Anemocyte.com
BIO International Convention
bio international convention

BIO International Convention

BIO International Convention 3-6 june 2024 | San Diego. Meet us at Italian Pavilion at booth #3623(Anemocyte table, H).

read more
1536 1152 Anemocyte.com
ISCT
international society gene therapy

ISCT

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to ISCT 2024 in Vancouver

read more
2400 1800 Anemocyte.com
ASGCT
ASGT meeting

ASGCT

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to ASGCT Annual Meeting 2024 in Baltimore

read more
2400 1800 Anemocyte.com

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | Anemocyte Inc. 1221 Brickell Avenue, Suite 1160 Miami FL 33131

VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961